Researchers at the Johns Hopkins Kimmel Cancer Center have developed a novel liquid biopsy approach to identify early-stage ...

Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced the launch of a novel ...

A study found that a blood test detecting ctDNA after surgery more accurately predicts recurrence and survival in patients with stage 3 colon cancer.

A new blood test analyzes DNA fragments to screen for 50 types of cancer simultaneously. The $949 Galleri test detected ...

New blood test could improve survival rates of deadly cancer - Pancreatic cancer is the fifth most common cause of cancer ...

Jan Burnett thinks her routine blood tests are behind her when she receives an explanation of benefits showing zero patient ...

Hone Health reports that chronic inflammation is a key factor in heart disease risk often overlooked in standard health ...

This week the fda approves the first ever blood test for diagnosing concussions, and a group of scientists develop a neural ...

A new blood test has been developed that could improve survival rates for pancreatic cancer, a disease frequently diagnosed ...

Grail has filed for Food and Drug Administration approval of its multi-cancer early detection test, the company said Thursday ...